TOKYO – Japan's National Cancer Center (NCC) and pharma major Takeda Pharmaceutical Co. Ltd. have joined forces to discover and develop cancer drugs in Japan and ensure their quick delivery to patients.

TOKYO – Japan’s National Cancer Center (NCC) and pharma major Takeda Pharmaceutical Co. Ltd. have joined forces to discover and develop cancer drugs in Japan and ensure their quick delivery to patients.

TOKYO – Two biotech companies from Japan are pooling complementary resources and products to tackle the rising incidence of dementia in a country with an aging population.

TOKYO – Two biotech companies from Japan are pooling complementary resources and products to tackle the rising incidence of dementia in a country with an aging population.

TOKYO – Japan is taking further steps to speed up reviews of innovative new drug and medical device applications through a new Sakigake designation. Sakigake roughly translates into "leading the way."

TOKYO – A lack of a commercial mindset is holding back Japan's biotech industry as academics find it difficult to move ideas from paper to market.

TOKYO – A lack of a commercial mindset is holding back Japan's biotech industry as academics find it difficult to move ideas from paper to market.

TOKYO – Japan's Eisai Co. Ltd. will work with multinational Merck & Co. Inc. to jointly develop combination cancer regimens.